ST
Starling Oncology, Inc.
STLN · NASDAQ
$6.99 +3.41% (+$0.23)
1M +13.54%
Market Cap $662.9M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$4.65
33.5% downside
Trenutna cena
$6.99
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica STLN trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/S 1.13x
P/E N/A
EV/EBITDA N/A
Growth
100 /100
Growing Rev. growth 25.81%
EPS growth N/A
FCF growth N/A
Profitability
5 /100
Weak Gross margin 15.69%
Net margin 6.18%
Op. margin 4.44%
Quality
21 /100
Poor ROIC 28.82%
ROA 20.36%
Asset turnover 3.29x
Debt
27 /100
High Current ratio 1.36x
Int. coverage -3.76x
Debt/Equity N/A
Stability
46 /100
Moderate Beta 0.44x
Rev. volatility 3.92%
EPS volatility 208.70%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o STLN
Online
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Daniel Virnich
Employees
641
Headquarters
Cerritos